The pharmacology of CGRP-responsive receptors in cultured and transfected cells

被引:25
作者
Hay, DL
Conner, AC
Howitt, SG
Takhshid, MA
Simms, J
Mahmoud, K
Poyner, DR [1 ]
机构
[1] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
[2] Univ Auckland, Liggins Inst, Auckland, New Zealand
[3] Univ Birmingham, Sch Biol Sci, Birmingham B15 2TT, W Midlands, England
[4] Shiraz Univ, Dept Biochem, Shiraz 71545, Iran
基金
英国生物技术与生命科学研究理事会;
关键词
CGRP; calcitonin receptor-like receptor; RAMP1; RAMP2; RAMP3; CL; CGRP(8-37); calcitonin receptor; BIBN4096BS;
D O I
10.1016/j.peptides.2004.06.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Historically, CGRP receptors have been classified as CGRP(1) or CGRP(2) subtypes, chiefly depending on their affinity for the antagonist CGRP(8-37). It has been shown that the complex between calcitonin receptor-like receptor (CRLR or CL) and receptor activity modifying protein (RAMP) 1 provides a molecular correlate for the CGRP(1) receptor; however, this does not explain the range of affinities seen for CGRP(8-37) in isolated tissues. It is suggested that these may largely be explained by a combination of methodological factors and CGRP-responsive receptors generated by CL and RAMP2 or RAMP3 and complexes of RAMPs with the calcitonin receptor. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:2019 / 2026
页数:8
相关论文
共 49 条
[41]  
Rorabaugh BR, 2001, J PHARMACOL EXP THER, V299, P1086
[42]   CCRP and adrenomedullin receptor populations in human cerebral arteries:: in vitro pharmacological and molecular investigations in different artery sizes [J].
Sams, A ;
Knyihár-Csillik, E ;
Engberg, J ;
Szok, D ;
Tajti, J ;
Bodi, I ;
Edvinsson, L ;
Vécsei, L ;
Jansen-Olesen, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 408 (02) :183-193
[43]   Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [3H]BIBN4096BS [J].
Schindler, M ;
Doods, HN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 442 (03) :187-193
[44]   Effects of alpha calcitonin gene-related peptide in human bronchial smooth muscle and pulmonary artery [J].
Springer, J ;
Amadesi, S ;
Trevisani, M ;
Harrison, S ;
Dinh, QT ;
McGregor, GP ;
Fischer, A ;
Geppetti, P ;
Groneberg, DA .
REGULATORY PEPTIDES, 2004, 118 (03) :127-134
[45]  
Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61
[46]   BIBN4096BS is a potent competitive antagonist of the relaxant effects of α-CGRP on human temporal artery:: comparison with CGRP(8-37) [J].
Verheggen, R ;
Bumann, K ;
Kaumann, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (01) :120-126
[47]  
Waugh DJJ, 1999, J PHARMACOL EXP THER, V289, P1419
[48]   Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens:: evidence for a [Cys(Et)2,7]hCGRP-preferring receptor [J].
Wu, DM ;
Eberlein, W ;
Rudolf, K ;
Engel, W ;
Hallermayer, G ;
Doods, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 400 (2-3) :313-319
[49]   Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity [J].
Yallampalli, C ;
Chauhan, M ;
Thota, CS ;
Kondapaka, S ;
Wimalawansa, SJ .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (06) :263-269